Plasma cell myeloma recurrent – Life with Disease

Go back

When multiple myeloma returns after treatment, it presents new challenges for patients and their families. Understanding what to expect and how to navigate this phase of the disease can help maintain quality of life and make informed decisions about care.

Understanding Prognosis When Myeloma Returns

When multiple myeloma comes back after treatment, the outlook varies significantly from person to person. The prognosis depends on several important factors, including how long the cancer was in remission, which treatments were used previously, and how well those treatments worked. The overall health and fitness of the patient also plays a crucial role in determining what lies ahead[1].

Multiple myeloma that has relapsed is considered an ongoing, chronic condition rather than something that can be permanently cured at this time. Most patients will experience several cycles of treatment and remission throughout the course of their disease. Each time the cancer returns, the goal of treatment shifts toward controlling the disease, reducing symptoms, and helping patients live as long as possible with the best quality of life[7].

The time between relapses can vary greatly. Some patients may remain in remission for several years after their first treatment, while others may experience a shorter period before the disease becomes active again. Generally, if the cancer stayed in remission for longer than 18 months, this is considered a more favorable sign. However, as the disease progresses through multiple relapses, the time between each episode may become shorter, and the cancer may become more difficult to control[10].

⚠️ Important

Patients who become “refractory” to treatment—meaning the disease continues to progress despite therapy—face more challenging circumstances. When myeloma becomes resistant to multiple classes of drugs, including protease inhibitors, immunomodulatory agents, and monoclonal antibodies, this is called “triple-class refractory” disease and carries a more serious prognosis[7].

Natural Progression Without Treatment

If relapsed multiple myeloma is left untreated, the disease will continue to advance and cause increasingly serious problems throughout the body. The abnormal plasma cells multiply rapidly in the bone marrow, taking up space that should be occupied by healthy blood-forming cells. This crowding effect leads to a cascade of complications that worsen over time[1].

As the disease progresses without intervention, patients typically experience worsening anemia, which is a shortage of red blood cells. This makes people feel increasingly tired and weak, and they may become short of breath even with minimal activity. The lack of energy can become so severe that it interferes with even the simplest daily tasks[4].

Bone damage is another serious consequence of untreated relapsed myeloma. The cancer cells activate other cells in the bone marrow that break down bone tissue, creating weak spots called osteolytic lesions. Over time, bones become increasingly fragile and prone to fractures. The spine, ribs, skull, and pelvis are commonly affected. As bones are destroyed, calcium is released into the bloodstream, leading to dangerously high calcium levels known as hypercalcemia. This condition can cause confusion, excessive thirst, nausea, and kidney problems[3].

The kidneys are particularly vulnerable as the disease advances. The abnormal proteins produced by myeloma cells can accumulate and damage the kidney’s filtering system. Without treatment, kidney function deteriorates progressively, potentially leading to complete kidney failure that requires dialysis, a medical procedure to filter waste from the blood when the kidneys can no longer perform this function[2].

The immune system becomes increasingly compromised as well. With fewer normal white blood cells to fight infections, patients become vulnerable to repeated and serious infections. These infections can become life-threatening, as the weakened immune system struggles to respond to bacteria, viruses, and other pathogens[4].

Possible Complications

Even with treatment, relapsed multiple myeloma can lead to a variety of complications that affect different parts of the body. Understanding these potential problems helps patients and caregivers recognize warning signs and seek prompt medical attention when needed.

Bone-related complications remain a significant concern throughout the course of the disease. Fractures can occur spontaneously or with minimal trauma, particularly in the spine. When vertebrae collapse or fracture, they can compress the spinal cord, causing severe pain, numbness, weakness in the legs, or even paralysis. This is considered a medical emergency requiring immediate treatment[3].

Infections represent one of the most common and dangerous complications for people with relapsed myeloma. The combination of the disease itself and the treatments used to control it suppresses the immune system. Patients may develop pneumonia, urinary tract infections, skin infections, or bloodstream infections that can quickly become serious. Fever, chills, persistent cough, or any signs of infection should be reported to the healthcare team immediately[4].

Kidney problems can develop or worsen at any point during the disease course. The buildup of abnormal proteins, dehydration, high calcium levels, and certain medications can all contribute to kidney damage. Some patients may need temporary or permanent dialysis. Monitoring kidney function regularly through blood tests is essential[2].

Nerve damage, called peripheral neuropathy, can result from both the disease and its treatment. Patients may experience tingling, numbness, burning sensations, or pain in their hands and feet. This can make it difficult to perform fine motor tasks like buttoning clothes or maintaining balance while walking. The discomfort can also interfere with sleep and daily activities[16].

Blood-related complications include severe anemia requiring transfusions, low platelet counts leading to easy bruising and bleeding, and increased risk of blood clots. The blood can also become thickened by the high levels of abnormal proteins, a condition called hyperviscosity syndrome, which can cause headaches, blurred vision, and bleeding problems[1].

Some patients develop a condition called amyloidosis, where abnormal proteins fold incorrectly and deposit in organs and tissues. These deposits can damage the heart, kidneys, liver, and nerves, creating additional health challenges beyond the myeloma itself[1].

Impact on Daily Life

Living with relapsed multiple myeloma affects nearly every aspect of daily life, from physical capabilities to emotional well-being, relationships, and practical matters. The disease creates a complex web of challenges that patients and their families must navigate together[17].

Physical limitations often become more pronounced when myeloma returns. Fatigue is typically the most overwhelming symptom, affecting more than 60 percent of patients at diagnosis and many more as the disease progresses. This is not ordinary tiredness that improves with rest. It is a profound exhaustion that can make even simple activities like taking a shower or preparing a meal feel like climbing a mountain. Many people find they need to rest frequently throughout the day and may struggle to maintain their previous level of activity[4].

Bone pain can significantly restrict movement and activity. Patients may need to avoid certain movements or activities that could increase the risk of fractures. Heavy lifting, high-impact exercise, and even bending or twisting movements may need to be limited or modified. Some people require assistive devices like canes or walkers to move safely. Fear of falling or breaking bones can lead some patients to become less active, which unfortunately can lead to muscle weakness and further limitations[16].

Work and career are often affected by relapsed myeloma. The frequent medical appointments, treatment schedules, and unpredictable symptoms can make it difficult to maintain regular employment. Some patients are able to continue working with accommodations, such as reduced hours or the ability to work from home. Others find they need to take extended medical leave or apply for disability benefits. The loss of professional identity and income can be emotionally challenging[14].

Social relationships and activities may change as well. The ongoing fatigue and need for frequent rest can make it hard to participate in social gatherings, family events, or hobbies that were once enjoyed. Some patients feel isolated, especially if they need to avoid crowds during times when their immune system is particularly weak. Friends and family members may not fully understand the invisible nature of many symptoms, leading to feelings of being misunderstood or unsupported[17].

Emotional and psychological effects are substantial. Many people experience anxiety about the future, fear of the disease progressing, and uncertainty about how long treatments will remain effective. Depression is common, particularly when dealing with chronic pain, fatigue, and the loss of independence. The stress of ongoing medical management, financial concerns, and changes in family roles can feel overwhelming at times[14].

Treatment side effects add another layer of complexity to daily life. Steroid medications, which are commonly used to treat myeloma, can cause weight gain, mood swings, difficulty sleeping, and increased appetite. These changes can affect self-image and emotional well-being. Neuropathy from certain treatments can make it difficult to feel textures, maintain balance, or perform tasks requiring fine motor control[16].

⚠️ Important

Despite these challenges, many people with relapsed myeloma find ways to adapt and maintain quality of life. Staying as physically active as possible within safe limits, maintaining social connections even if in modified ways, working with physical therapists, seeking support for emotional health, and focusing on activities that bring meaning and joy can all help. Open communication with the healthcare team about symptoms and concerns is essential for receiving appropriate support[14].

Practical daily management involves careful attention to infection prevention, including frequent handwashing, avoiding sick contacts, and staying up to date with recommended vaccinations. Maintaining good nutrition despite appetite changes, managing medications properly, and attending regular medical appointments all require organization and energy. Many patients benefit from creating systems and routines that make these tasks more manageable[15].

Sleep disturbances are common with relapsed myeloma, whether from pain, steroid medications, anxiety, or other symptoms. Poor sleep further worsens fatigue and affects overall well-being. Working with the healthcare team to address underlying causes and establish good sleep habits can make a meaningful difference[14].

Support for Family and Caregivers

Family members and caregivers play a vital role when someone has relapsed multiple myeloma. Understanding clinical trials and how to support a loved one through this process can be invaluable, as these research studies may offer access to promising new treatments not yet widely available[8].

Clinical trials are research studies that test new treatments or combinations of treatments to determine if they are safe and effective. For patients with relapsed myeloma, participating in a clinical trial might provide access to innovative therapies, particularly if standard treatments are no longer working well. Many of the treatments that are now considered standard care for myeloma were first proven effective through clinical trials[6].

Families should know that clinical trials have strict eligibility requirements based on factors like previous treatments received, current health status, and specific characteristics of the disease. Not every patient will qualify for every trial, and the healthcare team can help determine which trials might be appropriate options. It is important to understand that participating in a trial is completely voluntary, and patients can withdraw at any time[1].

When considering clinical trials, families can help by researching available studies together with the patient. Many cancer centers have clinical trial coordinators who can explain available options in detail. Online resources, including cancer research organizations and patient advocacy groups, maintain databases of ongoing trials. Taking notes during discussions with the healthcare team and asking questions about potential benefits, risks, procedures, and time commitments can help families make informed decisions[6].

Practical support from family members is crucial throughout the treatment journey. This might include accompanying the patient to appointments to provide another set of ears and help remember what was discussed, keeping track of medications and schedules, assisting with transportation to medical appointments, and helping with daily tasks when the patient is experiencing fatigue or other symptoms. However, caregivers must also remember to care for themselves, as caregiver burnout is common[17].

Emotional support is equally important. Simply being present and listening without trying to fix everything can be powerful. Acknowledging the difficulty of the situation while maintaining hope and focusing on what can be controlled helps patients feel less alone. Avoiding phrases like “stay positive” or “everything happens for a reason” is advisable, as these can minimize the patient’s legitimate struggles[14].

Understanding the symptoms and side effects that the patient is experiencing helps family members provide better support. Learning about what to watch for and when to seek medical help enables caregivers to act as additional advocates for the patient’s health and safety. Many cancer centers offer education sessions for families about disease management and caregiving strategies[13].

Financial and logistical support can relieve significant stress for patients. This might involve helping navigate insurance issues, exploring financial assistance programs, coordinating care among multiple healthcare providers, or managing practical matters like meal preparation or household tasks. Many hospitals have social workers and patient navigators who can connect families with community resources[14].

Communication within the family about roles, expectations, and concerns is essential. Relapsed myeloma affects the entire family system, not just the patient. Regular family meetings to discuss how everyone is doing, what support is needed, and how to distribute caregiving responsibilities can prevent misunderstandings and resentment. Children and other family members may have questions and concerns that need to be addressed in age-appropriate ways[17].

Support groups specifically for caregivers of people with myeloma provide opportunities to share experiences with others who understand the unique challenges. These groups, whether in-person or online, offer practical advice, emotional support, and validation. Many caregivers find tremendous relief in connecting with others who truly understand their situation[13].

Encouraging the patient’s independence and decision-making, even when trying to be helpful, is important for maintaining their dignity and sense of control. Rather than taking over completely, asking “How can I help?” or “What do you need right now?” respects the patient’s autonomy while offering support[14].

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of relapsed or refractory multiple myeloma, based on the provided sources:

  • Daratumumab (Darzalex®) – A monoclonal antibody that targets the CD38 pathway on myeloma cells, approved for advanced multiple myeloma
  • Elotuzumab (Empliciti®) – A monoclonal antibody that targets the SLAMF7 pathway, approved for patients with advanced multiple myeloma
  • Isatuximab (Sarclisa®) – A monoclonal antibody that targets the CD38 pathway, approved for patients with advanced multiple myeloma
  • Teclistimab (Tecvayli™) – A bispecific T cell engager antibody that targets BCMA on tumor cells and CD3 on T cells, approved for certain patients with multiple myeloma
  • Ciltacabtagene autoleucel (Carvykti™) – A BCMA-targeting CAR T cell immunotherapy approved for subsets of patients with advanced multiple myeloma
  • Idecabtagene vicleucel (Abecma™) – A BCMA-targeting CAR T cell immunotherapy approved for subsets of patients with advanced multiple myeloma
  • Bortezomib – A protease inhibitor used in various combination regimens for relapsed multiple myeloma
  • Lenalidomide – An immunomodulatory agent used in combination therapies for relapsed disease
  • Pomalidomide – An immunomodulatory agent used in combination with dexamethasone for relapsed myeloma
  • Carfilzomib – A protease inhibitor used in combination therapies for relapsed multiple myeloma
  • Ixazomib – A protease inhibitor used in combination with lenalidomide and dexamethasone for relapsed disease
  • Panobinostat – Used in combination with bortezomib and dexamethasone for certain relapsed cases
  • Selinexor – Used in combination with dexamethasone for patients with relapsed or refractory disease
  • Elranatamab – An immunotherapy option for patients with relapsed multiple myeloma
  • Dexamethasone – A steroid used in multiple combination regimens for relapsed myeloma

Ongoing Clinical Trials on Plasma cell myeloma recurrent

  • Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Czechia France Germany Greece Hungary Italy +4

References

https://www.cancer.gov/types/myeloma/patient/myeloma-treatment-pdq

https://www.ncbi.nlm.nih.gov/books/NBK534764/

https://www.mayoclinic.org/diseases-conditions/multiple-myeloma/symptoms-causes/syc-20353378

https://themmrf.org/multiple-myeloma/

https://www.cdc.gov/myeloma/about/index.html

https://www.cancerresearch.org/immunotherapy-by-cancer-type/multiple-myeloma

https://www.ncbi.nlm.nih.gov/books/NBK592405/

https://www.cancer.gov/types/myeloma/patient/myeloma-treatment-pdq

https://pmc.ncbi.nlm.nih.gov/articles/PMC5554888/

https://www.cancerresearchuk.org/about-cancer/myeloma/treatment/treatment-when-myeloma-comes-back

https://www.texasoncology.com/types-of-cancer/multiple-myeloma/recurrent-multiple-myeloma

https://www.ncbi.nlm.nih.gov/books/NBK65924/

https://www.cancer.org/cancer/types/multiple-myeloma/after-treatment/follow-up.html

https://www.healthline.com/health/multiple-myeloma/lifestyle-tips

https://www.nature.com/articles/s41408-021-00560-x

https://www.webmd.com/cancer/multiple-myeloma/rrmm-lifestyle

https://pmc.ncbi.nlm.nih.gov/articles/PMC5947652/

FAQ

What does it mean when multiple myeloma is relapsed?

Relapsed multiple myeloma means the disease has come back after a period of remission following treatment. During remission, there were no signs of active myeloma in the body. When it relapses, the cancer cells become detectable again and may start causing symptoms[10].

How is relapsed myeloma different from refractory myeloma?

Relapsed myeloma means the disease came back after responding to previous treatment. Refractory myeloma means the cancer isn’t responding to current treatment or stopped responding during treatment. Some patients have relapsed and refractory disease, meaning it came back and also isn’t responding to therapy[7].

Will I receive the same treatment I had before when my myeloma relapses?

The treatment for relapsed myeloma depends on several factors. If your remission lasted longer than 18 months, you might receive the same combination of drugs. However, it’s more common to try a different combination of medications. Your doctor will consider which treatments you’ve had before, how well they worked, your overall health, and which drugs are available[10].

Can lifestyle changes help when myeloma comes back?

Yes, healthy lifestyle behaviors can improve quality of life and physical functioning for people with relapsed myeloma. Staying physically active within safe limits can help manage pain, reduce fatigue, strengthen bones, and improve mood. Eating a balanced diet, maintaining good sleep habits, and managing weight are also important for overall well-being[15].

Should I consider a clinical trial for relapsed myeloma?

Clinical trials can be a valuable option for patients with relapsed multiple myeloma, as they may provide access to new treatments not yet widely available. Many of today’s standard treatments for myeloma were first proven effective through clinical trials. Your healthcare team can help determine if you’re eligible for any trials and explain the potential benefits and risks[6].

🎯 Key takeaways

  • Most patients with multiple myeloma will experience several cycles of treatment and relapse throughout the course of their disease
  • The prognosis for relapsed myeloma depends on how long the previous remission lasted, which treatments were used before, and the patient’s overall health
  • Without treatment, relapsed myeloma leads to worsening anemia, bone damage, kidney problems, and increased vulnerability to infections
  • Complications can include bone fractures, spinal cord compression, severe infections, kidney failure, nerve damage, and blood-related problems
  • Fatigue is one of the most overwhelming symptoms, affecting over 60% of patients and impacting nearly every aspect of daily life
  • Physical activity within safe limits can help manage symptoms, improve mood, strengthen bones, and maintain overall quality of life
  • Clinical trials offer access to new treatments and may be particularly valuable when standard therapies are no longer effective
  • Family members and caregivers play crucial roles in providing practical, emotional, and logistical support while also needing to care for themselves